(Q36463399)

14 August 2017

F8 haplotype and inhibitor risk: results from the Hemophilia Inhibitor Genetics Study (HIGS) Combined Cohort (English)

1 reference

14 August 2017

0 references

5

S M Donfield

1 reference

14 August 2017

6

E D Gomperts

1 reference

14 August 2017

11

C A Winkler

1 reference

14 August 2017

J Schwarz

1

1 reference

14 August 2017

J Astermark

2

1 reference

14 August 2017

E D Menius

3

1 reference

14 August 2017

M Carrington

4

1 reference

14 August 2017

G W Nelson

7

1 reference

14 August 2017

J Oldenburg

8

1 reference

14 August 2017

A Pavlova

9

1 reference

14 August 2017

A D Shapiro

10

1 reference

14 August 2017

E Berntorp

12

1 reference

14 August 2017

Hemophilia Inhibitor Genetics Study Combined Cohort

13

1 reference

14 August 2017

7 September 2012

1 reference

14 August 2017

1 reference

14 August 2017

19

1 reference

14 August 2017

1

1 reference

14 August 2017

113-118

1 reference

Inhibitors of factor VIII in black patients with hemophilia

14 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3521089

Review: a gentle introduction to imputation of missing values

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3521089

Principal components analysis corrects for stratification in genome-wide association studies

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3521089

Inference of population structure using multilocus genotype data: linked loci and correlated allele frequencies

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3521089

Inhibitor development in correlation to factor VIII genotypes

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3521089

The role of genetics in inhibitor formation

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3521089

Incidence of inhibitors in haemophilia A patients--a review of recent studies of recombinant and plasma-derived factor VIII concentrates

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3521089

Inversions disrupting the factor VIII gene are a common cause of severe haemophilia A

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3521089

A multicenter study of recombinant factor VIII (recombinate): safety, efficacy, and inhibitor risk in previously untreated patients with hemophilia A. The Recombinate Study Group

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3521089

The Malmö International Brother Study (MIBS): further support for genetic predisposition to inhibitor development in hemophilia patients

28 June 2018

1 reference

Impact of polymorphisms of the major histocompatibility complex class II, interleukin-10, tumor necrosis factor-alpha and cytotoxic T-lymphocyte antigen-4 genes on inhibitor development in severe hemophilia A.

21 January 2018

1 reference

Polymorphisms in the IL10 but not in the IL1beta and IL4 genes are associated with inhibitor development in patients with hemophilia A.

21 January 2018

1 reference

Polymorphisms in the TNFA gene and the risk of inhibitor development in patients with hemophilia A.

21 January 2018

1 reference

Polymorphisms in the CTLA-4 gene and inhibitor development in patients with severe hemophilia A.

21 January 2018

1 reference

Clinical evaluation of an advanced category antihaemophilic factor prepared using a plasma/albumin-free method: pharmacokinetics, efficacy, and safety in previously treated patients with haemophilia A.

21 January 2018

1 reference

Safety and efficacy of KOGENATE Bayer in previously untreated patients (PUPs) and minimally treated patients (MTPs).

21 January 2018

1 reference

Mutation profiling in haemophilia A

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22958194

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

A multicenter study of recombinant factor VIII (Recombinate) in previously treated patients with hemophilia A. The Recombinate Previously Treated Patient Study Group

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22958194

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1111/HAE.12004

1 reference

14 August 2017

1 reference

14 August 2017

PubMed publication ID

22958194

1 reference